mitomycin has been researched along with Keratitis in 6 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Keratitis: Inflammation of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was designed to evaluate the long term results of intraoperative mitomycin C in patients with one recurrence of pterygium." | 9.08 | Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. ( Carpineto, P; Ciancaglini, M; Enrico Gallenga, P; Mastropasqua, L, 1996) |
| " A history included marginal keratitis and conjunctival squamous cell carcinoma treated with excision and topical mitomycin-C." | 7.96 | Inflammatory-induced astigmatism: acute changes in corneal curvature secondary to marginal keratitis and previous mitomycin-C treatment. ( Hossain, RR; McKelvie, J, 2020) |
| "To perform a qualitative assessment of the topical side-effects of mitomycin C on cornea after pterygium surgery." | 7.75 | Corneal and conjunctival findings after mitomycin C application in pterygium surgery: an in-vivo confocal microscopy study. ( Beck, R; Guthoff, RF; Zhivov, A, 2009) |
| "The study was designed to evaluate the long term results of intraoperative mitomycin C in patients with one recurrence of pterygium." | 5.08 | Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. ( Carpineto, P; Ciancaglini, M; Enrico Gallenga, P; Mastropasqua, L, 1996) |
| "To perform a qualitative assessment of the topical side-effects of mitomycin C on cornea after pterygium surgery." | 3.75 | Corneal and conjunctival findings after mitomycin C application in pterygium surgery: an in-vivo confocal microscopy study. ( Beck, R; Guthoff, RF; Zhivov, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hossain, RR | 1 |
| McKelvie, J | 1 |
| Zhivov, A | 1 |
| Beck, R | 1 |
| Guthoff, RF | 1 |
| Carpineto, P | 2 |
| Agnifili, L | 1 |
| Nubile, M | 1 |
| Fasanella, V | 1 |
| Doronzo, E | 1 |
| Mastropasqua, A | 1 |
| Ciancaglini, M | 2 |
| Bowers, PJ | 1 |
| Price, MO | 1 |
| Zeldes, SS | 1 |
| Price, FW | 1 |
| Singh, RP | 1 |
| McCluskey, P | 1 |
| Mastropasqua, L | 1 |
| Enrico Gallenga, P | 1 |
1 trial available for mitomycin and Keratitis
| Article | Year |
|---|---|
Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium.
Topics: Adult; Antibiotics, Antineoplastic; Case-Control Studies; Combined Modality Therapy; Female; Follow- | 1996 |
5 other studies available for mitomycin and Keratitis
| Article | Year |
|---|---|
Inflammatory-induced astigmatism: acute changes in corneal curvature secondary to marginal keratitis and previous mitomycin-C treatment.
Topics: Astigmatism; Cornea; Humans; Keratitis; Male; Middle Aged; Mitomycin; Visual Acuity | 2020 |
Corneal and conjunctival findings after mitomycin C application in pterygium surgery: an in-vivo confocal microscopy study.
Topics: Administration, Topical; Adult; Aged; Conjunctiva; Cornea; Corneal Edema; Drug Administration Schedu | 2009 |
Conjunctival and corneal findings in bleb-associated endophthalmitis: an in vivo confocal microscopy study.
Topics: Aged; Aged, 80 and over; Blister; Case-Control Studies; Conjunctivitis; Endophthalmitis; Female; Gla | 2011 |
Superficial keratectomy with mitomycin-C for the treatment of Salzmann's nodules.
Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Cornea; Corneal Diseases; Female; Follow-Up Studies; Human | 2003 |
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy | 2005 |